The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International. Its Cleaning segment consists of laundry, home care and professional products marketed and sold in the United States. Its Household segment consists of charcoal, cat litter and plastic bags, wraps and container products marketed and sold in the United States. Its Lifestyle segment consists of food products, water-filtration systems and filters, and natural personal care products marketed and sold in the United States. Its International segment consists of products sold outside the United States. It markets some of the consumer brand names, such as namesake bleach and cleaning products, Pine-Sol cleaners, Liquid-Plumr clog removers and Kingsford charcoal.
Industry, Sector and Symbol:
- Sector: Non-Cyclical Consumer Goods & Services
- Industry: Household Products - NEC
- Sub-Industry: Household Products
- Symbol: NYSE:CLX
- CUSIP: 18905410
- Web: www.thecloroxcompany.com/
- Market Cap: $17.03 billion
- Outstanding Shares: 128,798,000
- 50 Day Moving Avg: $135.68
- 200 Day Moving Avg: $132.27
- 52 Week Range: $111.24 - $141.76
Sales & Book Value:
- Trailing P/E Ratio: 26.12
- Foreward P/E Ratio: 23.24
- P/E Growth: 3.55
- Annual Revenue: $5.93 billion
- Price / Sales: 2.87
- Book Value: $3.14 per share
- Price / Book: 42.11
- Annual Dividend: $3.36
- Dividend Yield: 2.6%
- EBIDTA: $1.22 billion
- Net Margins: 11.65%
- Return on Equity: 204.72%
- Return on Assets: 15.00%
- Debt-to-Equity Ratio: 3.44%
- Current Ratio: 0.80%
- Quick Ratio: 0.55%
- Average Volume: 687,197 shs.
- Beta: 0.4
- Short Ratio: 6.83
Frequently Asked Questions for Clorox Co (NYSE:CLX)
What is Clorox Co's stock symbol?
Clorox Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLX."
How often does Clorox Co pay dividends? What is the dividend yield for Clorox Co?
Clorox Co announced a quarterly dividend on Monday, May 8th. Stockholders of record on Wednesday, July 19th will be given a dividend of $0.84 per share on Friday, August 4th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.54%. The ex-dividend date of this dividend is Monday, July 17th. This is a positive change from Clorox Co's previous quarterly dividend of $0.80. View Clorox Co's Dividend History.
How were Clorox Co's earnings last quarter?
Clorox Co (NYSE:CLX) posted its quarterly earnings results on Wednesday, May, 3rd. The company reported $1.31 EPS for the quarter, topping the Zacks' consensus estimate of $1.30 by $0.01. The business had revenue of $1.48 billion for the quarter, compared to analysts' expectations of $1.48 billion. Clorox Co had a net margin of 11.65% and a return on equity of 204.72%. The business's quarterly revenue was up 3.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.21 EPS. View Clorox Co's Earnings History.
When will Clorox Co make its next earnings announcement?
What guidance has Clorox Co issued on next quarter's earnings?
Clorox Co issued an update on its FY17 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share guidance of $5.25-5.35 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.32. The company issued revenue guidance of +3-4% to ~$5.93-5.99 billion, compared to the consensus revenue estimate of $5.97 billion.
Where is Clorox Co's stock going? Where will Clorox Co's stock price be in 2017?
12 equities research analysts have issued 1-year target prices for Clorox Co's shares. Their predictions range from $76.00 to $144.00. On average, they expect Clorox Co's stock price to reach $126.27 in the next year. View Analyst Ratings for Clorox Co.
Who are some of Clorox Co's key competitors?
Some companies that are related to Clorox Co include Imperial Brands PLC (IMB), Associated British Foods plc (ABF), Mead Johnson Nutrition CO (MJN), Tesco PLC (TSCO), Kerry Group Public Ltd Co (KYGA), Coca Cola HBC AG (CCH), US Foods Holding Corp (USFD), WM Morrison Supermarkets PLC (MRW), J Sainsbury plc (SBRY), Booker Group Plc (BOK), Sprouts Farmers Market (SFM), Tate & Lyle PLC (TATE), Performance Food Group Co (PFGC), Homeserve plc (HSV), Fevertree Drinks PLC (FEVR), Britvic Plc (BVIC), PZ Cussons plc (PZC) and AA PLC (AA).
Who are Clorox Co's key executives?
Clorox Co's management team includes the folowing people:
- Benno O. Dorer, Chairman of the Board, Chief Executive Officer
- Stephen M. Robb, Chief Financial Officer, Executive Vice President
- Laura Stein J.D., Executive Vice President, General Counsel, Corporate Affairs
- James E. Foster, Executive Vice President - Product Supply, Enterprise Performance and IT
- Dawn Willoughby, Executive Vice President, Chief Operating Officer - Cleaning, International & Professional Products, Corporate Strategy
- Manjit Singh, Senior Vice President, Chief Information Officer
- Eric H. Reynolds, Senior Vice President, Chief Marketing Officer
- Jon M. Balousek, Senior Vice President, General Manager - Specialty Division
- William S. Bailey, Senior Vice President – Corporate Business Development
- Michael J. Costello, Senior Vice President, International
Who owns Clorox Co stock?
Clorox Co's stock is owned by many different of retail and institutional investors. Top institutional shareholders include APG Asset Management N.V. (0.77%), Bank of Montreal Can (0.29%), KAMES CAPITAL plc (0.26%), First Quadrant L P CA (0.17%), US Bancorp DE (0.14%) and State of Alaska Department of Revenue (0.10%). Company insiders that own Clorox Co stock include A D David Mackay, Dawn C Willoughby, Frank A Tataseo, Jacqueline P Kane, James E Foster, Jon M Balousek, Laura Stein, Nikolaos A Vlahos, Stephen Robb and Thomas D Johnson. View Institutional Ownership Trends for Clorox Co.
Who sold Clorox Co stock? Who is selling Clorox Co stock?
Clorox Co's stock was sold by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, First Quadrant L P CA, US Bancorp DE, Nisa Investment Advisors LLC, Franklin Street Advisors Inc. NC, Exxonmobil Investment Management Inc. TX, Chevy Chase Trust Holdings Inc. and Hills Bank & Trust Co.. Company insiders that have sold Clorox Co stock in the last year include Dawn C Willoughby, Jon M Balousek, Laura Stein and Nikolaos A Vlahos. View Insider Buying and Selling for Clorox Co.
Who bought Clorox Co stock? Who is buying Clorox Co stock?
Clorox Co's stock was bought by a variety of institutional investors in the last quarter, including Forsta AP Fonden, Mn Services Vermogensbeheer B.V., Webster Bank N. A., National Pension Service, Manning & Napier Advisors LLC, Aperio Group LLC, Fox Run Management L.L.C. and Oakmont Partners LLC. View Insider Buying and Selling for Clorox Co.
How do I buy Clorox Co stock?
Shares of Clorox Co can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Clorox Co's stock price today?
MarketBeat Community Rating for Clorox Co (NYSE CLX)MarketBeat's community ratings are surveys of what our community members think about Clorox Co and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Clorox Co stock can currently be purchased for approximately $132.24.
Consensus Ratings for Clorox Co (NYSE:CLX) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||10 Hold Ratings, 2 Buy Ratings|
|Consensus Rating:||Hold (Score: 2.17)|
|Consensus Price Target: ||$126.27 (4.51% downside)|
Analysts' Ratings History for Clorox Co (NYSE:CLX)
(Data available from 7/23/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|7/22/2017||Deutsche Bank AG||Reiterated Rating||Hold||$126.00 -> $137.00||N/A|
|6/30/2017||Royal Bank Of Canada||Reiterated Rating||Hold||$115.00||Low|
|5/4/2017||BMO Capital Markets||Reiterated Rating||Buy||$136.00||Medium|
|5/3/2017||Jefferies Group LLC||Set Price Target||Hold||$138.00||Low|
|4/7/2017||Citigroup Inc.||Boost Price Target||Neutral||$75.00 -> $76.00||Low|
|3/21/2017||J P Morgan Chase & Co||Initiated Coverage||Neutral -> Neutral||$136.00||Low|
|2/18/2017||Barclays PLC||Set Price Target||Hold||$140.00||N/A|
|2/11/2017||B. Riley||Reiterated Rating||Neutral||$125.00||N/A|
|12/16/2016||Morgan Stanley||Upgrade||Underweight -> Equal Weight||$112.00||N/A|
|11/15/2016||Wells Fargo & Company||Reiterated Rating||Market Perform||N/A|
|9/16/2016||Atlantic Securities||Upgrade||Hold -> Buy||$144.00||N/A|
|8/4/2016||Goldman Sachs Group, Inc. (The)||Reiterated Rating||Neutral||$130.00||N/A|
|2/26/2016||Sterne Agee CRT||Downgrade||Buy -> Neutral||N/A|
|11/3/2015||Sanford C. Bernstein||Boost Price Target||Market-Perform||$111.00 -> $116.00||N/A|
|8/4/2015||Bank of America Corporation||Reiterated Rating||Underperform||$110.00 -> $118.00||N/A|
Earnings History for Clorox Co (NYSE:CLX)Earnings History by Quarter for Clorox Co (NYSE CLX)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/3/2017||Q3 2017||$1.30||$1.31||$1.48 billion||$1.48 billion||View||Listen|
|2/3/2017||Q217||$1.22||$1.25||$1.41 billion||$1.41 billion||View||N/A|
|11/2/2016||Q117||$1.42||$1.36||$1.24 billion||$1.44 billion||View||N/A|
|8/3/2016||Q416||$1.28||$1.26||$1.58 billion||$1.60 billion||View||Listen|
|5/3/2016||Q316||$1.11||$1.21||$1.41 billion||$1.43 billion||View||N/A|
|2/4/2016||Q216||$1.05||$1.14||$1.35 billion||$1.35 billion||View||Listen|
|11/2/2015||Q116||$1.18||$1.32||$1.37 billion||$1.39 billion||View||Listen|
|8/3/2015||Q415||$1.37||$1.44||$1.52 billion||$1.56 billion||View||N/A|
|5/1/2015||Q315||$1.10||$1.08||$1.38 billion||$1.40 billion||View||Listen|
|2/4/2015||Q215||$0.90||$0.97||$1.30 billion||$1.35 billion||View||Listen|
|10/31/2014||Q115||$1.03||$1.10||$1.33 billion||$1.35 billion||View||Listen|
|8/1/2014||Q4||$1.34||$1.40||$1.52 billion||$1.51 billion||View||Listen|
|5/1/2014||Q314||$1.08||$1.18||$1.43 billion||$1.39 billion||View||N/A|
|2/4/2014||Q214||$0.91||$0.88||$1.31 billion||$1.33 billion||View||N/A|
|10/31/2013||Q114||$1.01||$1.04||$1.35 billion||$1.36 billion||View||N/A|
|8/1/2013||Q4 2013||$1.34||$1.38||$1.57 billion||$1.55 billion||View||N/A|
|5/1/2013||Q3 2013||$1.06||$1.00||$1.44 billion||$1.41 billion||View||N/A|
|2/4/2013||Q2 2013||$0.80||$0.90||$1.27 billion||$1.33 billion||View||N/A|
|10/31/2012||Q113||$0.95||$1.01||$1.35 billion||$1.34 billion||View||N/A|
Earnings Estimates for Clorox Co (NYSE:CLX)
2017 EPS Consensus Estimate: $5.49
2018 EPS Consensus Estimate: $5.71
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Current Dividend Information for Clorox Co (NYSE:CLX)
|Dividend Growth:||5.20% (3 Year Average)|
|Payout Ratio:||66.27% (Trailing 12 Months of Earnings) |
63.28% (Based on This Year's Estimates)
59.05% (Based on Next Year's Estimates)
|Track Record:||39 Years of Consecutive Dividend Growth|
Dividend History by Quarter for Clorox Co (NYSE CLX)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Clorox Co (NYSE:CLX)
Insider Ownership Percentage: 0.74%Insider Trades by Quarter for Clorox Co (NYSE:CLX)
Institutional Ownership Percentage: 70.75%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|12/1/2016||A D David Mackay||Director||Buy||5,000||$114.90||$574,500.00|| |
|9/2/2016||Laura Stein||EVP||Sell||38,882||$131.69||$5,120,370.58|| |
|8/29/2016||Jon M Balousek||SVP||Sell||5,136||$131.14||$673,535.04|| |
|8/17/2016||Dawn C Willoughby||COO||Sell||10,617||$131.01||$1,390,933.17|| |
|8/10/2016||Nikolaos A. Vlahos||COO||Sell||925||$133.07||$123,089.75|| |
|5/10/2016||Nikolaos A Vlahos||COO||Sell||2,151||$132.25||$284,469.75|| |
|2/24/2016||Dawn C Willoughby||COO||Sell||1,550||$129.00||$199,950.00|| |
|2/8/2016||Nikolaos A. Vlahos||COO||Sell||8,589||$126.60||$1,087,367.40|| |
|12/7/2015||Jon M Balousek||SVP||Sell||1,488||$128.69||$191,490.72|| |
|12/4/2015||Jacqueline P Kane||EVP||Sell||852||$127.55||$108,672.60|| |
|12/3/2015||Thomas D Johnson||VP||Sell||908||$126.09||$114,489.72|| |
|11/27/2015||Jacqueline P Kane||EVP||Sell||2,160||$125.45||$270,972.00|| |
|11/25/2015||Thomas D. Johnson||VP||Sell||12,679||$125.04||$1,585,382.16|| |
|11/19/2015||Laura Stein||EVP||Sell||12,700||$124.42||$1,580,134.00|| |
|11/17/2015||Stephen Robb||CFO||Sell||30,496||$122.02||$3,721,121.92|| |
|11/12/2015||James E. Foster||EVP||Sell||5,684||$122.24||$694,812.16|| |
|11/11/2015||Laura Stein||EVP||Sell||17,577||$124.21||$2,183,239.17|| |
|11/4/2015||Dawn C. Willoughby||COO||Sell||29,349||$124.06||$3,641,036.94|| |
|11/4/2015||Laura Stein||EVP||Sell||8,716||$124.50||$1,085,142.00|| |
|10/6/2015||Stephen Robb||CFO||Sell||19,125||$119.00||$2,275,875.00|| |
|9/25/2015||Jacqueline P Kane||EVP||Sell||2,340||$115.00||$269,100.00|| |
|9/25/2015||Stephen Robb||CFO||Sell||21,020||$115.00||$2,417,300.00|| |
|9/18/2015||Stephen Robb||CFO||Sell||8,500||$113.85||$967,725.00|| |
|9/17/2015||Jacqueline P Kane||EVP||Sell||5,027||$115.00||$578,105.00|| |
|9/14/2015||James E. Foster||EVP||Sell||11,999||$109.34||$1,311,970.66|| |
|9/8/2015||Jon M Balousek||SVP||Sell||1,294||$111.38||$144,125.72|| |
|9/2/2015||Frank A Tataseo||EVP||Sell||3,673||$110.25||$404,948.25|| |
|8/28/2015||Thomas D Johnson||VP||Sell||1,051||$111.34||$117,018.34|| |
|8/27/2015||James E Foster||EVP||Sell||3,000||$111.39||$334,170.00|| |
|8/20/2015||Nikolaos A Vlahos||COO||Sell||4,800||$116.12||$557,376.00|| |
|6/16/2015||Jeffrey T Klenda||Director||Buy||394,257||$0.20||$78,851.40|
|3/25/2015||Jeffrey T Klenda||Director||Buy||25,000||$0.16||$3,875.00|
|3/23/2015||Dawn C Willoughby||COO||Sell||5,440||$112.00||$609,280.00|| |
|3/16/2015||Stephen Robb||CFO||Sell||25,279||$109.49||$2,767,797.71|| |
|2/12/2015||Nikolaos A Vlahos||COO||Sell||16,018||$108.01||$1,730,104.18|| |
|2/10/2015||Frank A Tataseo||EVP||Sell||86,087||$107.01||$9,212,169.87|| |
|2/6/2015||Donald R Knauss||Chairman||Sell||272,780||$106.83||$29,141,087.40|| |
|1/9/2015||James E Foster||EVP||Sell||19,048||$106.68||$2,032,040.64|| |
|1/5/2015||Jacqueline P Kane||SVP||Sell||23,534||$103.76||$2,441,887.84|| |
|12/22/2014||Donald R Knauss||Chairman||Sell||270,853||$104.06||$28,184,963.18|| |
|12/8/2014||Nikolaos A Vlahos||COO||Sell||7,394||$99.60||$736,442.40|| |
|11/26/2014||James E Foster||EVP||Sell||15,315||$99.74||$1,527,518.10|| |
|11/26/2014||Thomas D Johnson||VP||Sell||25,006||$99.52||$2,488,597.12|| |
|11/25/2014||Jacqueline P Kane||SVP||Sell||43,430||$99.50||$4,321,285.00|| |
|11/13/2014||Dawn C Willoughby||COO||Sell||4,034||$102.02||$411,548.68|| |
|11/13/2014||Michael R Costello||SVP||Sell||16,348||$102.00||$1,667,496.00|| |
|11/3/2014||George C Roeth||COO||Sell||198,159||$99.46||$19,708,894.14|| |
|9/22/2014||Jacqueline P Kane||SVP||Sell||43,960||$97.00||$4,264,120.00|| |
|8/25/2014||Benno O Dorer||COO||Sell||2,505||$89.12||$223,245.60|| |
|6/9/2014||Thomas D Johnson||VP||Sell||23,737||$89.44||$2,123,037.28|| |
|5/20/2014||Thomas Britanik||CMO||Sell||1,779||$88.48||$157,405.92|| |
|5/8/2014||Thomas Britanik||CMO||Sell||21,320||$88.00||$1,876,160.00|| |
|4/29/2014||Wayne Delker||SVP||Sell||14,819||$92.00||$1,363,348.00|| |
|3/27/2014||Dawn Willoughby||SVP||Sell||2,595||$90.00||$233,550.00|| |
|12/3/2013||Grant Lamontagne||SVP||Sell||71,860||$93.01||$6,683,698.60|| |
|11/22/2013||Jon Balousek||SVP||Sell||3,125||$93.72||$292,875.00|| |
|11/7/2013||Thomas P Britanik||CMO||Sell||5,834||$92.03||$536,903.02|| |
|11/5/2013||Carolyn M Ticknor||Director||Sell||8,000||$90.01||$720,080.00|| |
|10/29/2013||Benno O Dorer||COO||Sell||15,577||$90.25||$1,405,824.25|| |
|10/29/2013||Frank A Tataseo||EVP||Sell||25,200||$90.27||$2,274,804.00|| |
|7/9/2013||Benno O Dorer||COO||Sell||25,714||$85.14||$2,189,289.96|| |
|6/14/2013||Frank A Tataseo||EVP||Sell||1,197||$85.17||$101,948.49|| |
|6/3/2013||Thomas P Britanik||CMO||Sell||2,278||$83.59||$190,418.02|| |
|5/29/2013||Tully M Friedman||Director||Sell||3,000||$84.79||$254,370.00|| |
|5/24/2013||Michael R Costello||VP||Sell||1,217||$85.98||$104,637.66|| |
|5/16/2013||Thomas P Britanik||CMO||Sell||34,258||$87.81||$3,008,194.98|| |
|5/15/2013||George J Harad||Director||Sell||5,497||$87.19||$479,283.43|| |
|5/15/2013||Grant J Lamontagne||SVP||Sell||19,350||$87.62||$1,695,447.00|| |
|5/7/2013||Nikolaos A Vlahos||SVP||Sell||3,769||$86.15||$324,699.35|| |
|2/22/2013||Larry Peiros||COO||Sell||77,200||$83.00||$6,407,600.00|| |
|2/1/2013||Larry Peiros||COO||Sell||10,678||$79.24||$846,124.72|| |
|2/1/2013||Stephen Robb||CFO||Sell||8,781||$79.29||$696,245.49|| |
|12/10/2012||George J Harad||Director||Buy||3,000||$75.95||$227,850.00|| |
|12/4/2012||Laura Stein||SVP||Sell||26,780||$76.34||$2,044,385.20|| |
Headline Trends for Clorox Co (NYSE:CLX)
Latest Headlines for Clorox Co (NYSE:CLX)
Clorox Co (CLX) Chart for Sunday, July, 23, 2017